These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11983121)

  • 21. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
    Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute haemoperitoneum due to spontaneous tumour rupture as first manifestation of hepatocellular carcinoma].
    Abdel Samie A; Otto G; Theilmann L
    Z Gastroenterol; 2007 Jul; 45(7):615-9. PubMed ID: 17620227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient.
    Gonzalez L; Blanc JF; Sa Cunha A; Rullier A; Saric J; Le Bail B; Balabaud C; Bioulac-Sage P
    Semin Liver Dis; 2004 Nov; 24(4):415-9. PubMed ID: 15605309
    [No Abstract]   [Full Text] [Related]  

  • 25. Peritoneal lavage with distilled water during liver resection in patients with spontaneously ruptured hepatocellular carcinomas.
    Lin CH; Hsieh HF; Yu JC; Chen TW; Yu CY; Hsieh CB
    J Surg Oncol; 2006 Sep; 94(3):255-6. PubMed ID: 16900516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budd-Chiari syndrome and hepatocellular carcinoma.
    Kage M
    J Gastroenterol; 2004 Jul; 39(7):706-7. PubMed ID: 15293149
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of cyclin A in hepatocellular carcinoma and its relationship with HBx gene integration.
    Zhang Y; Peng Z; Qiu G; Wang Z; Gu W
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):353-5. PubMed ID: 12408762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role and mechanism of cytokines in the carcinogenesis of liver carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):378-9. PubMed ID: 15918976
    [No Abstract]   [Full Text] [Related]  

  • 32. Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma.
    Li WH; Cheuk EC; Kowk PC; Cheung MT
    J Hepatobiliary Pancreat Surg; 2009; 16(4):508-12. PubMed ID: 19381430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary study on cellular status of selenium and oxidative stress in human hepatocellular carcinoma and normal liver].
    Chen C; Deng G; Zhao J; Gao Y; Zhang P; Li B; Chai Z; Peng S
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):543-6. PubMed ID: 15612474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
    Izumi N
    J Gastroenterol; 2003; 38(9):918-20. PubMed ID: 14564643
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transarterial embolization for hemorrhage due to spontaneous rupture in hepatocellular carcinoma].
    Yang Y; Cheng H; Xu A; Chen D; Wang Y; Yao X; Chen H; Wu M
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):285-7. PubMed ID: 12515628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
    Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
    Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerosing haemangioma mimicking hepatocellular carcinoma.
    Lee VT; Magnaye M; Tan HW; Thng CH; Ooi LL
    Singapore Med J; 2005 Mar; 46(3):140-3. PubMed ID: 15735880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver transplantation for hepatocellular carcinoma: status quo and experience in Kyushu University].
    Soejima Y; Taketomi A; Ikegami T; Yoshizumi T; Uchiyama H; Gion T; Sugimachi K; Nagata S; Maehara Y
    Fukuoka Igaku Zasshi; 2008 May; 99(5):95-101. PubMed ID: 18788452
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.